Stockscreener 앱 받기
71.32
0.49%
-0.35
시간 외 거래:
71.32
전일 마감가:
$71.67
열려 있는:
$71.4
하루 거래량:
2.24M
Relative Volume:
1.03
시가총액:
$11.78B
수익:
$943.38M
순이익/손실:
$-380.99M
주가수익비율:
-28.91
EPS:
-2.4667
순현금흐름:
$-325.67M
1주 성능:
-1.41%
1개월 성능:
-14.22%
6개월 성능:
+16.90%
1년 성능:
+113.92%
1일 변동 폭
$70.51
$71.94
1주일 범위
$70.42
$74.16
52주 변동 폭
$23.95
$86.74
Ionis Pharmaceuticals Inc Stock (IONS) Company Profile
명칭
Ionis Pharmaceuticals Inc
전화
(760) 931-9200
주소
2855 GAZELLE COURT, CARLSBAD, CA
Compare IONS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IONS
Ionis Pharmaceuticals Inc
|
71.32 | 11.84B | 943.38M | -380.99M | -325.67M | -2.4667 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-28 | 재개 | Barclays | Overweight |
| 2025-10-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-26 | 업그레이드 | Goldman | Sell → Neutral |
| 2025-09-03 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-07-31 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-04-07 | 개시 | H.C. Wainwright | Buy |
| 2025-03-31 | 개시 | Redburn Atlantic | Neutral |
| 2024-08-02 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-07-24 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-07-16 | 재개 | Jefferies | Buy |
| 2024-06-14 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2024-04-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-01-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-23 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-09-29 | 개시 | Raymond James | Strong Buy |
| 2023-07-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-06-07 | 재개 | Piper Sandler | Overweight |
| 2023-05-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-03-21 | 개시 | Bernstein | Underperform |
| 2022-12-21 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-09-09 | 재개 | Morgan Stanley | Overweight |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2022-03-31 | 재개 | Piper Sandler | Overweight |
| 2022-03-01 | 개시 | Citigroup | Sell |
| 2022-03-01 | 개시 | Guggenheim | Buy |
| 2022-02-01 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-12-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2021-05-07 | 업그레이드 | UBS | Sell → Neutral |
| 2021-03-01 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-12-16 | 개시 | UBS | Sell |
| 2020-12-15 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-09-14 | 재개 | JP Morgan | Neutral |
| 2020-09-02 | 개시 | The Benchmark Company | Hold |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-13 | 개시 | Oppenheimer | Outperform |
| 2019-11-13 | 개시 | BofA/Merrill | Buy |
| 2019-11-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2019-09-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2018-08-08 | 재확인 | Stifel | Hold |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-05-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2017-10-06 | 재개 | Goldman | Sell |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-08-09 | 재확인 | Stifel | Hold |
| 2017-03-10 | 다운그레이드 | Goldman | Neutral → Sell |
| 2016-12-28 | 재확인 | BMO Capital Markets | Outperform |
| 2016-12-27 | 재확인 | Leerink Partners | Mkt Perform |
모두보기
Ionis Pharmaceuticals Inc 주식(IONS)의 최신 뉴스
Affiliate files Form 144 to sell shares — IONS (NASDAQ: IONS) - Stock Titan
Hudson Bay Capital Management LP Decreases Stock Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Groupama Asset Managment - MarketBeat
Insider Sell: Elizabeth Hougen Sells 225,220 Shares of Ionis Pha - GuruFocus
Did Ionis Pharmaceuticals' (IONS) Board Refresh and Return of Peter Reikes Just Shift Its Investment Narrative? - simplywall.st
Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 215,048 Shares of Stock - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells $744,692.12 in Stock - MarketBeat
Ionis Pharmaceuticals (NASDAQ: IONS) CFO sells 225,220 shares after option exercises - Stock Titan
Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), BioMarin Pharmaceutical (BMRN) and Ionis Pharmaceuticals (IONS) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS), Airsculpt Technologies (AIRS) and NRX Pharmaceuticals (NRXP) - The Globe and Mail
BlueCrest Capital Management Ltd Makes New Investment in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Alpine Global Management LLC Acquires 30,463 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Retail Trends: Can Ionis Pharmaceuticals Inc outperform in the next rally2026 Rallies & Stock Market Timing Techniques - baoquankhu1.vn
Bamco Inc. NY Makes New $1.64 Million Investment in Ionis Pharmaceuticals, Inc. $IONS - National Today
Goldman Sachs Upgrades Ionis Pharmaceuticals (IONS) - MSN
IONS (IONS) Form 144 notices proposed resale of 225,200 shares - Stock Titan
Ionis Pharmaceuticals (IONS) Among Most Oversold Healthcare Stocks - GuruFocus
Ionis Pharmaceuticals, Inc. $IONS Shares Purchased by Jain Global LLC - MarketBeat
BlueCrest Capital Management Ltd Takes Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Cinctive Capital Management LP Invests $11.37 Million in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Boone Capital Management LLC Takes $27.34 Million Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Baker BROS. Advisors LP Makes New $37.08 Million Investment in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Ionis Pharmaceuticals Stock (ISIN: US46120E6023) Faces Pressure Amid Biotech Volatility - AD HOC NEWS
Algert Global LLC Grows Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Ionis outlines >$2B peak sales target for olezarsen as new launches and pipeline catalysts drive 2026 outlook - MSN
IONS SEC FilingsIonis Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
Atika Capital Management Invests $1.41M in Ionis Pharmaceuticals - National Today
Connor Clark & Lunn Investment Management Ltd. Raises Stake in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Atika Capital Management LLC Invests $1.41 Million in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Insider Sell: Brett Monia Sells 160,773 Shares of Ionis Pharmace - GuruFocus
Ionis Pharmaceuticals (NASDAQ:IONS) CEO Sells $9,525,584.00 in Stock - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) CEO Brett Monia Sells 34,103 Shares of Stock - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Patrick O'neil Sells 10,148 Shares - MarketBeat
Ionis Pharmaceuticals Presents at Barclays Healthcare Conference - National Today
Ionis Pharmaceuticals (IONS) EVP executes 10b5-1 sale of 10,148 shares - Stock Titan
Ionis Pharmaceuticals (IONS) CEO exercises options and sells 160,773 shares - Stock Titan
Ionis (NASDAQ: IONS) EVP sells 37,277 shares under 10b5-1 plan - Stock Titan
Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy - Biogen
Capital World Investors Has $832.32 Million Holdings in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Ionis Pharmaceuticals Inc at Leerink Global Healthcare Conference Transcript - GuruFocus
Ionis Pharma director Diaz sells $4.35m in IONS stock By Investing.com - Investing.com Nigeria
IONS (Nasdaq: IONS) insider notice: 37,277 shares from option exercises - Stock Titan
Ionis pharma director Loscalzo sells $82k in shares - Investing.com Nigeria
Ionis pharma director Klein sells $1.7 million in IONS stock - Investing.com Nigeria
Ionis Pharmaceuticals at Leerink Global Healthcare: Strategic Moves in 2026 By Investing.com - Investing.com Canada
Ionis Pharmaceuticals Announces Board Changes: Parshall and Wender to Retire, Reikes Rejoins in 2026 - Minichart
Ionis announces changes to Board of Directors - pharmiweb.com
Ionis Pharmaceuticals Announces Board Retirements and New Appointment - TipRanks
Ionis Pharmaceuticals (NASDAQ: IONS) plans board refresh as Parshall, Wender retire and Reikes returns - Stock Titan
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Ionis Pharmaceuticals Inc (IONS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):